Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Do we have a vaccine for HIV now?!!!

Red algae as an alternative for non-biodegradable plastic!

Surprisingly Fast Transport in Carbon Nanotube Membranes Could Advance Human Health

Do we have a vaccine for HIV now?!!!
  • BiotechToday
  • World

Do we have a vaccine for HIV now?!!!

bioxone February 12, 2021February 12, 2021

CAMELIA BHATTACHARYYA, AMITY UNIVERSITY KOLKATA

HIV or Human Immunodeficiency virus was first discovered in the early 1980s. It later became an epidemic and it still scares people since there’s still no vaccine known to protect us against it. Does that mean that the scientists and researchers are not trying to even make one? Well no. Since the 1980s there have been a number of studies conducted to fight against AIDS (Acquired Immune Deficiency Syndrome), starting from ART (Antiretroviral Therapy), the most effective one to date and different ways to treat patients even with modifications in the dosage and application of ART. But then these are not a lifetime cure and a person with controlled HIV is still capable of transmitting the virus through sexual intercourse, blood transfusion, etc. So what’s the way out of this difficulty now? Though not totally accepted, and is recommended to undergo more studies, yet a bit of light of hope has been shown by a recent study conducted by Murakowski and his teammates.

The HIV virus has a high rate of mutation which holds researchers from making a vaccine; a single vaccine can’t fight against all these new strains. Also, the proteome of the entire virus when used on vectors was not found to be that useful. Thus, only a part of the HIV proteome was used to make a single long peptide immunogen. This was inserted in adenovirus vectors. These when tested on Macaques, gave amazing results. These vaccines seem to weaken the mutated strains of the virus, thus making the new strain less lethal on the host. The T-cell responses weaken the fitness level in the virus thus affecting the succeeding viral generations, all of which keep targeting the selected regions provided in the single long peptide immunogen for the loss in its fitness. This study confirms that a vaccine for HIV is now possible and further experimentation would bring a chance to cure AIDS forever by vaccinating humans. Hope this experiment goes a long way without restricting its study only on Macaques and homo sapiens win over a microorganism yet again with the help of the weapon called “application of scientific knowledge”.

Also read:Red algae as an alternative for non-biodegradable plastic!

Source: D.K. Murakowski, J.P. Barton, L. Peter, A. Chandrashekar, E. Bondzie, A. Gao, D.H. Barouch, and A.K. Chakraborty. “Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques”. PNAS February 2, 2021 118 (5) e2022496118; doi:10.1073/pnas.2022496118

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged AIDS epidemic HIV Mutation VACCINE

One thought on “Do we have a vaccine for HIV now?!!!”

  1. Pingback: Surprisingly Fast Transport in Carbon Nanotube Membranes Could Advance Human Health - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Surprisingly Fast Transport in Carbon Nanotube Membranes Could Advance Human Health

bioxone February 12, 2021

Sagnik Nag , Amity University, Kolkata Hemodialysis is a treatment procedure wherein the blood is filtered from metabolic wastes and water, exactly mimicking the work of our healthy kidneys. Recently Lawrence Livermore National Laboratory (LLNL) researchers have claimed to discover that the carbon nanotube membrane pores would enable ultra-rapid dialysis processes which would efficiently reduce […]

Membranes

Related Post

  • BiotechToday
  • World

Mitral Valve Replacement in children and infants

BioTech Today July 29, 2021July 29, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University ‘Lub-Dub’ is the sound the heart makes every time it beats. It is probably one of the most easily recognizable sounds. The heart is one of the most essential organs in the body, pumping blood to all the parts of the body. It is required to transport […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Plant-based Meat Production

bioxone December 11, 2020December 11, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA Animal-based meat production has grown over the years to meet the demand for cost-effective and appetizing food. However, this treat is accompanied by unnoticed consequences for human health, the environment, and the animals involved. Focusing on the rise in global meat demand, researchers, and entrepreneurs are focusing on plant-based approaches […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Discovery of new prodrugs by new 3D culture platform assures treatment of Type 1 diabetes

bioxone December 21, 2020December 21, 2020

Devyani Goswami, Amity University Kolkata The individuals having Type 1 diabetes have a loss of β cells. They are unable to synthesize insulin properly; insulin injections and pluripotent stem cell-derived β cells (SC β cells) have clothed to be promising treatment but not as effective as there remain certain drawbacks. The 2D cell cultures lack […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy